Patents Assigned to The Cleveland Clinic Foundation
  • Patent number: 11559528
    Abstract: Provided herein are compositions, systems, kits, and methods for treating a subject with cancer by administering a BACE1 inhibitor, such as MK-8931. In particular embodiments, the subject is treated with radiation (e.g., low dose radiation) first, and then administered a BACE1 inhibitor within a certain time window (e.g., about 3 hours to 6 days after the radiation treatment).
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: January 24, 2023
    Assignee: The Cleveland Clinic Foundation
    Inventors: Shideng Bao, Kui Zhai
  • Patent number: 11557383
    Abstract: Described herein is a system for remote monitoring of non-critically ill hospitalized patients. The system can include a graphical user interface displaying a representation of the patient census. Each patient is represented by a graphic showing a clinical status, with an underlying expanded view of various parameters. The system can also include a non-transitory memory storing computer executable instructions and a processor configured to execute the computer executable instructions. Upon execution, the computer executable instructions can at least: receive a data stream associated with a non-critically ill hospitalized patient; determine a risk score associated with the non-critically ill hospitalized patient based on data associated with the alarm notification, wherein the risk score represents a probability of the non-critically ill hospitalized patient developing an actionable clinical event; and rearrange the plurality of graphical representations on the GUI based on the risk score.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: January 17, 2023
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Daniel J. Cantillon, Molly Loy
  • Patent number: 11547560
    Abstract: A method is provided for implanting a valve having at least one valve leaflet within the cardiovascular system of a subject. One step of the method includes preparing a substantially dehydrated bioprosthetic valve and then providing an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends. Next, the substantially dehydrated bioprosthetic valve is attached to the expandable support member so that the substantially dehydrated bioprosthetic valve is operably secured within the main body portion of the expandable support member. The expandable support member is then crimped into a compressed configuration and placed at a desired location within the cardiovascular system of the subject. Either before or after placement at the desired location, fluid or blood re-hydrates the substantially dehydrated bioprosthetic valve.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: January 10, 2023
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Jose Luis Navia, Ji-Feng Chen
  • Patent number: 11547749
    Abstract: Compositions and methods for immunization against human breast cancer are disclosed. A breast cancer vaccine comprises an immunogenic polypeptide comprising human ?-lactalbumin.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: January 10, 2023
    Assignee: The Cleveland Clinic Foundation
    Inventors: Vincent K. Tuohy, Justin M. Johnson, Ritika Jaini
  • Patent number: 11540796
    Abstract: Embodiments discussed herein facilitate generation of a prognosis for recurrence or non-recurrence of atrial fibrillation (AF) after pulmonary vein isolation (PVI). A first set of embodiments discussed herein relates to training of a machine learning classifier to determine a prognosis for AF after PVI based on radiographic images, alone or in combination with clinical features. A second set of embodiments discussed herein relates to determination of a prognosis for a patient for AF after PVI based on radiographic images, alone or in combination with clinical features.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: January 3, 2023
    Assignees: Case Western Reserve University, The Cleveland Clinic Foundation
    Inventors: Anant Madabhushi, Michael LaBarbera, Thomas Atta-Fosu, Mina Chung
  • Patent number: 11541196
    Abstract: One aspect of the present disclosure can include an intubating airway. The intubating airway can include a first component (14) having a first guiding surface and a second articulating component (16) that is attached to the first component via a hinge and has a second guiding surface. In a closed configuration, the first and second guiding surfaces can be flush with one another so that the first and second components collectively define a conduit having an interior passage that is dimensioned to direct a fiber-optic scope or an endotracheal tube extending through the interior passage for tracheal intubation. In an open configuration, the first and second guiding surfaces are not flush with one another so that no such conduit is formed.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: January 3, 2023
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Donn Marciniak, Erik Kraenzler
  • Patent number: 11534203
    Abstract: An introducer sheath is provided for inserting at least one medical instrument directly toward a target patient tissue site. A plurality of lumens extend longitudinally between sheath proximal and distal ends of the introducer sheath. A septum extends between the sheath proximal and distal ends and selectively laterally separates each of the sheath lumens from one another. The septum is at least partially formed from a deformable and elastomeric material. The septum has a biased condition in which the plurality of sheath lumens are at least partially isolated from one another. The septum is selectively deflectable from the biased condition to at least partially place at least one of the plurality of sheath lumens in fluid communication with at least one other of the plurality of sheath lumens.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: December 27, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Karunakaravel Karuppasamy
  • Patent number: 11523768
    Abstract: A method of identifying an epileptogenic zone of a subjects brain includes: receiving a plurality N of physiological brain signals that extend over a duration, each of the plurality N of physiological brain signals acquired from the subjects brain; calculating within a time window a state transition matrix based on at least a portion of each of the plurality N of physiological brain signals, wherein the state transition matrix is a linear time invariant model of a network of N nodes corresponding to the plurality N of physiological brain signals; calculating a minimum norm of a perturbation on the state transition matrix that causes the network to transition from a stable state to an unstable state; and assigning a fragility metric to each of the plurality N of physiological brain signals based on the minimum norm of the perturbation for that physiological brain signal.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: December 13, 2022
    Assignees: The Johns Hopkins University, The Cleveland Clinic Foundation
    Inventors: Sridevi Sarma, Adam Li, Jorge Gonzalez-Martinez
  • Patent number: 11524945
    Abstract: The present invention relates to compounds that are modulators of Integrin Linked Kinase (ILK), and methods of treating diseases with such compounds. In certain embodiments, the compounds are within Formulas I-VII (e.g., Csbl-1). In some embodiments, the compounds are used to treat an ILK-mediated disease, such as cancer (e.g., triple negative breast cancer) or an inflammatory disease.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: December 13, 2022
    Assignee: The Cleveland Clinic Foundation
    Inventors: Jun Qin, Koichi Fukuda, Julia Vaynberg, Suguna Rachakonda
  • Patent number: 11517692
    Abstract: A ventilator conduit for a reversible airway device (RAD) is provided. The RAD can include a supra-glottic support member connected to a tubular guide (TG) having oppositely disposed proximal and distal end portions and TG lumen, which extends between the ends and is defined by an inner surface. The RAD can be physically free of an endotracheal tube. The ventilator conduit can include a hollow tube having first and second ends, and a ventilator conduit lumen extending between the ends. The first and second ends can be adapted for connection to a ventilator circuit and insertion into the TG lumen, respectively. At least the second end of the hollow tube can be sized and dimensioned so that, upon insertion into the TG, an outer surface of the second end is brought into direct contact with a portion of the inner surface to form an air-tight seal therebetween.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: December 6, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Rafi Avitsian
  • Patent number: 11490848
    Abstract: Systems and methods for electrocardiographic waveform analysis, data presentation and actionable alert generation are described. Electrocardiographic waveform data can be received from a wearable device associated with a patient. A mathematical analysis of at least a portion of the electrocardiographic waveform data can be performed to provide cardiac analytics. In instances where (1) a pathologically prolonged QT interval and (2) an R on T premature ventricular contraction and/or a ventricular tachycardia are detected from the cardiac analytics of the at least a portion of the electrocardiographic waveform data, an actionable alert can be generated and displayed with a visualization of the cardiac analytics.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: November 8, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Daniel J. Cantillon
  • Patent number: 11491350
    Abstract: For decision support in a medical therapy, machine learning provides a machine-learned generator for generating a prediction of outcome for therapy personalized to a patient. The outcome prediction may be used to determine dose. To assist in decision support, a regression analysis of the cohort used for machine training relates the outcome from the machine-learned generator to the dose and an actual control time (e.g., time-to-event). The dose that minimizes side effects while minimizing risk of failure to a time for any given patient is determined from the outcome for that patient and a calibration from the regression analysis.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: November 8, 2022
    Assignees: Siemens Healthcare GmbH, The Cleveland Clinic Foundation
    Inventors: Bin Lou, Ali Kamen, Nilesh Mistry, Lance Anthony Ladic, Mohamed Abazeed
  • Patent number: 11491333
    Abstract: One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters associated with a therapy signal from the power source. The at least one electrode can be configured to deliver the therapy signal to a target tissue associated with control of a posterior base of the tongue of the subject.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: November 8, 2022
    Assignee: The Cleveland Clinic Foundation
    Inventor: Francis A. Papay
  • Patent number: 11491192
    Abstract: A method of treating or preventing overgrowth by pathogenic bacteria in a subject deficient in butyrate and/or butyrate-producing bacteria in their gut microbiota by administering a therapeutically effective amount of a butyrate-producing bacteria to the subject is described. A prebiotic can be included with the butyrate-producing bacteria. Overgrowth by pathogenic bacteria is commonly caused by antibiotic administration.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: November 8, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Gail Cresci
  • Patent number: 11484711
    Abstract: This disclosure relates to using stereo-thermo-lesioning (STL) to create lesions at one or more locations in the patient's nervous system at the patient's bedside without general anesthesia. A method that uses STL to treat a patient's neurological condition includes: using a plurality of stereotactically-implanted thermo-coupled multi-contact electrodes to record conduction data within a predetermined theoretical zone of activity within the patient's neurological tissue; detecting abnormal neurological activity of a neurological condition within the conduction data and localize a portion of the predetermined theoretical zone of activity that is responsible for a primary organization of the abnormal neurological activity; creating a lesion at the portion of the predetermined theoretical zone of activity that is responsible for a primary organization of the abnormal neurological activity using at least one contact of the plurality of thermo-coupled multi-contact electrodes.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: November 1, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Jorge A. Gonzalez-Martinez, John T. Gale, Andre G. Machado, Imad Najm
  • Patent number: 11471098
    Abstract: Systems and methods are provided for monitoring the effects of therapeutics on the brain. Brains of first and second sets of patients are imaged and a gene expression is measured at a first time to provide a first set of images and a first set of gene expression transcripts. A therapeutic is administered to the first set of patients after the first time. The brains of the patients are imaged and the gene expression of the patients is measured at a second time, after the therapeutic is administered, to provide a second set of images and a second set of gene expression transcripts. A change in the brain is determined for the patients from the sets of images. A set of changes in the gene expression that are correlated with the changes in the brain are determined from the change in the brain and the sets of gene expression transcripts.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: October 18, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Amit Anand
  • Patent number: 11475561
    Abstract: Systems and methods are provided for automated identification of acute aortic syndromes in computed tomography images. A region of interest in a chest of a patient is imaged via a computed tomography (CT) scanner to provide images at a plurality of locations. The region of interest includes one of an ascending aorta, an aortic arch, and a descending aorta of the patient. For each of the plurality of locations within the region of interest, a value representing a variation in radiodensity values within the location is determined from the image to provide a set of variation values. A parameter representing a likelihood that the patient is experiencing an acute aortic syndrome is determined via a derived model from the set of variation values. The parameter representing the likelihood that the patient is experiencing the acute aortic syndrome is provided to a user at an associated output device.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 18, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Paul Schoenhagen, Po-Hao Chen, David Piraino, Nancy Obuchowski
  • Patent number: 11471111
    Abstract: This disclosure relates to a system and method to implement a performance test to help evaluate a patient's neurological and cognitive function. The performance test can be executed by the patient autonomously using a portable computing device, such as a tablet computer or smart phone. The portable computing device can be programmed to execute a set of modules configured to assess motor and cognitive performance, such as a manual function test module, a cognitive processing speed test module, and a movement assessment test module. The set of modules can also include a collection module to aggregate test data from the manual function test module, the cognitive processing speed test module, and the movement assessment test module.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: October 18, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Jay L. Alberts, Richard A. Rudick, David D. Schindler, Joshua Hirsch, Stephen M. Rao, Francois Bethoux, Susan Linder, Deborah Miller
  • Patent number: 11471037
    Abstract: Systems and methods are provided for evaluating an eye using retinal fluid volumes to provide a clinical parameter. An optical coherence tomography (OCT) image of an eye of a patient is obtained. The OCT image is segmented to produce a total retinal volume and one or both of a subretinal fluid volume and an intraretinal fluid volume for a region of interest within the eye. A metric is generated as a function of the total retinal volume and one or both of the subretinal fluid volume and the intraretinal fluid volume. A clinical parameter for the patient is determined from the metric. The determined clinical parameter is provided to a user at a display.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: October 18, 2022
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Justis P. Ehlers, Atsuro Uchida, Sunil Srivastava
  • Publication number: 20220323752
    Abstract: One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters associated with a therapy signal from the power source. The at least one electrode can be configured to deliver the therapy signal to a target tissue associated with control of a posterior base of the tongue of the subject.
    Type: Application
    Filed: April 26, 2022
    Publication date: October 13, 2022
    Applicant: The Cleveland Clinic Foundation
    Inventor: Francis A. PAPAY